Koers EPIRUS Biopharmaceuticals, Inc.
Aandelen
EPRSQ
US29428P1075
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- USD | -.--% | -.--% | -.--% |
2016 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016 | |
2015 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015 |
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,65 | Marktkapitalisatie | 75,33 mln. 69,48 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -37,82 mln. | Nettowinst (verlies) 2015 | -52 mln. -47,96 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,08 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,39 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 26 | |
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,40% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |